Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

2 weeks ago 11
The acquisition brings a caller attack to treating allergic diseases to the company’s immunology pipeline.
Read Entire Article
  1. Homepage
  2. Technology
  3. Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

Related

How to Switch AI Chatbots—and Why You Might Want To

How to Switch AI Chatbots—and Why You Might Want To

9 hours ago 3
Record-breaking Artemis II mission ends with 'perfect splashdown' in Pacific Ocean

Record-breaking Artemis II mission ends with 'perfect splash...

19 hours ago 2
China’s state media turns to social media and AI to tell its story — and often mock the US

China’s state media turns to social media and AI to tell its...

21 hours ago 5

Popular

Bryan Cranston on his new role - inspired by the complicated relationship with his father

Bryan Cranston on his new role - inspired by the complicated...

6 days ago 17
Canada's Artemis II astronaut gives thumbs-up to 'Project Hail Mary' starring Canadian Ryan Gosling

Canada's Artemis II astronaut gives thumbs-up to 'Project Ha...

6 days ago 16
Simple Bread Pudding, Spring Vegetables Every Which Way and Hot Cross Buns

Simple Bread Pudding, Spring Vegetables Every Which Way and ...

6 days ago 14
Stephen Miller Is Still Pursuing His Immigration Agenda, but More Quietly

Stephen Miller Is Still Pursuing His Immigration Agenda, but...

6 days ago 13
The Historic Turnaround That Took Michigan From Disaster to the Title Game

The Historic Turnaround That Took Michigan From Disaster to ...

6 days ago 13
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved